CR Bard Inc. (NYSE: BCR) is a large market cap stock with a market cap of 17403.98. It is in the Medical Instruments & Supplies industry and sector Healthcare, with a current P/E of 104.94, a forward P/E of 21.04 and EPS of 2.26. At a stock price of 236.95 (0.94%) it has a dividend yield of 0.44%.
EPS growth for the last five years have been -19.80%, more recently this last year it has grown by -52.90%. The next year growth is going to be about 10.90% and more long-term 10.80% after five years. EPS growth quarter over quarter is -16.70%. Sales growth for the past five years have been 4.70% and sales growth quarter over quarter is 6.60%.
For performance, CR Bard Inc. the past week has seen a gain of 5.30%. For the last month performance for CR Bard Inc. is 7.40%. While the last quarter is 16.95% and half year, 29.17%. Finally for the year, performance is 38.99%.
The 52-week high for CR Bard Inc., is at 0.06%, and for the 52-week low it comes to a value of 40.85%. The 20-day simple moving average is 7.24% and 19.98% for the 200-day simple moving average.
Volatility for the week is at 1.35%, and for the month it is 1.44%. CR Bard Inc., has a target price of 229.64.
In terms of debt, long term debt/equity is 0.78, and for total debt/equity CR Bard Inc. has 1.14. The gross margin is 62.20%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1.5 and the quick ratio is 1.2.
Insider ownership is at 0.50%, with instituitional ownership at 90.70%. CR Bard Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 73.45. The shares float is 73.17, with the float short at 1.58%, with short ratio coming to 2.49.
In terms of returns, the return on assets see CR Bard Inc., get *TBA, with its returns on investment at 6.40%. Return on equity is *TBA. So will the investors see the target price of 229.64, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.